Activin and bone morphogenetic protein (BMP) signalling during tooth development

European Journal of Oral Sciences

Volumn 106, Issue 1 SUPPL., 1998, Pages 167-173

  Heikinheimo, Kristiina ^a,b   Bègue Kirn, Catherine ^c   Ritvos, Olli ^b   Tuuri, Timo ^b   Ruch, Jean Victor ^c  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Activin A; BMPs; Follistatin; Odontogenesis; TGF receptors

Indexed keywords

ACTIVIN; ACTIVIN RECEPTOR; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR; CELL SURFACE RECEPTOR; FOLLISTATIN; GLYCOPROTEIN; GROWTH FACTOR RECEPTOR; INHIBIN; MESSENGER RNA;

ANIMAL; GENE EXPRESSION REGULATION; GENETICS; IN VITRO STUDY; METABOLISM; MOUSE; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; TOOTH DEVELOPMENT;

ACTIVIN RECEPTORS; ACTIVINS; ANIMALS; BONE MORPHOGENETIC PROTEIN RECEPTORS; BONE MORPHOGENETIC PROTEINS; FOLLISTATIN; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLYCOPROTEINS; INHIBINS; MICE; ODONTOGENESIS; RECEPTORS, CELL SURFACE; RECEPTORS, GROWTH FACTOR; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 0031608331     PISSN: 09098836     EISSN: 16000722     Source Type: Journal    
DOI: 10.1111/j.1600-0722.1998.tb02171.x     Document Type: Article

References (61)

1. MATZUK MM, KUMAR TR, VASSALLI A, BICKENBACH JR, ROOP DR, JAENISCH R. Functional analysis of activins during mammalian development. Nature 1995; 374: 354-356.
2. HOGAN BLM. Bone morphogenetic proteins in development. Curr Opin Genes Dev 1996; 6: 432-438.
3. ROBERTS VJ, SAWCHENKO PE, VALE WW. Expression of inhibin/activin subunit messenger ribonucleic acids during rat embryogenesis. Endocrinology 1991; 134: 914-923.
4. ROBERTS VJ, BARTH SL. Expression of messenger ribonucleic acids encoding the inhibin/activin system during mid- and late-gestation rat embryogenesis. Endocrinology 1994; 134: 914-923.
5. HEIKINHEIMO K, BÈGUE-KIRN C, RITVOS O, TUURI T, RUCH JV. The activin-binding protein follistatin is expressed in developing tooth and induces odontoblast-like differentiation in vitro. J Dent Res 1997; 76: 1625-1636.
6. LYONS KM, PELTON RW, HOGAN BLM. Organogenesis and pattern formation in the mouse: RNA distribution patterns suggest a role for bone morphogenetic protein-2A (BMP-2A). Development 1990; 109: 833-844.
7. BÈGUE-KIRN C, SMITH AJ, RUCH JV, WOZNEY JM, PURCHIO A, HARTMANN D, LESOT H. Effects of dentin proteins, transforming growth factor-β1 (TGF-β1) and bone morphogenetic protein 2 (BMP2) on the differentiation of odontoblasts in vitro. Int J Dev Biol 1992; 36: 491-503.
8. BÈGUE-KIRN C, SMITH AJ, LORIOT M, KUPFERLE C, RUCH JV, LESOT H. Comparative analysis of TGFβs, BMPs, IGFs, msxs, fibronectin, osteonectin and bone sialoprotein gene expressions during normal and in vitro induced odontoblast differentiation. Int J Dev Biol 1994; 38: 405-420.
9. VAINIO S, KARAVANOVA I, JOWETT A, THESLEFF I. Identification of BMP-4 as a signal mediating secondary induction between epithelial and mesenchymal tissues during tooth development. Cell 1993; 75: 45-58.
10. HEIKINHEIMO K. Stage-specific expression of decapentaplegic-Vg-related genes 2, 4 and 6 (bone morphogenetic proteins 2, 4 and 6) during human tooth morphogenesis. J Dent Res 1994; 73: 590-597.
11. HELDER MN, ÖZKAYNAK E, SAMPATH KT, LUYTEN FP, LATIN V, OPPERMANN H, VUKICEVIC S. Expression pattern of osteogenic protein-1 (bone morphogenetic protein-7) in human and mouse development. J Histochem Cytochem 1995; 43: 1035-1044.
12. VAAHTOKARI A, ÅBERG T, JERNVALL J, KERÄNEN S, THESLEFF I. The enamel knot as a signaling center in the developing mouse tooth. Mech Dev 1996; 54: 39-43.
13. FEIJEN A, GOUMANS MJ, VAN DEN EIJNDEN-VAN RK AJM. Expression of activin subunits, activin receptors and follistatin in postimplantation mouse embryos suggest specific development functions for different activins. Development 1994; 120: 3621-3637.
14. DEWULF N, VERSCHUEREN K, LONNOY O, MORÉN A, GRIMSBY S, VANDE SPIEGLE K, MIYAZONO K, HUYLEBROECK D, TEN DIJKE P. Distinct spatial and temporal expression patterns of two type I receptors for bone morphogenetic proteins during mouse embryogenesis. Endocrinology 1995; 136: 2652-2663.
15. MATZUK MM, LU N, VOGEL H, SELLHEYER K, ROOP DR, BRADLEY A. Multiple defects and perinatal death in mice deficient in follistatin. Nature 1995; 374: 360-363.
16. VERSCHUEREN K, DEWULF N, GOUMANS M-J, LONNOY O, FEIJEN A, GRIMSBY S, VANDE SPIEGLE K, TEN DIJKE P, MORÉN A, VANSCHEEUWIJK P, HELDIN C-H, MIYAZONO K, MUMMERY C, VAN DEN EIJNDEN-VAN RAAIJ J, HUYLEBROEK D. Expression of type I and type IB receptors for activin in midgestation mouse embryos suggests distinct functions in organogenesis. Mech Dev 1995; 52: 109-123.
17. MATZUK MM, KUMAR TR, BRADLEY A. Different phenotypes for mice deficient in either activins or activin receptor type II. Nature 1995; 374. 356-359.
18. KINGSLEY DM. The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 1994; 8: 133-146.
19. MASSAGUÉ J. TGF-β signaling: receptors, transducers and Mad proteins. Cell 1996; 85: 947-950.
20. VALE WW, HSUEH A, RIVIER C, YU J. The inhibin/activin family of hormones and growth factors. In: SPORN MB, ROBERTS AB, eds. Peptide growth factors and their receptors II. Berlin: Springer-Verlag, 1990; 211-248.
21. MICHEL U, FARNWORTH P, FINLAY JK. Follistatins: more than follicle-stimulating hormone suppressing proteins. Mol Cell Endocrinol 1993; 91: 1-11.
22. KLEIN PS, MELTON DA. Hormonal regulation of embryogenesis: the formation of mesoderm in Xenopus laevis. Endocr Rev 1994; 15: 326-341.
23. TSUCHIDA K, VAUGHAN JM, WIATER E, GADDY-KURTEN D, VALE WW. Inactivation of activin-dependent transcription by kinase-deficient activin receptors. Endocrinology 1995; 136: 5493-5503.
24. ATTISANO L, WRANA JL, MONTALVO E, MASSAGUÉ J. Activation of signalling by the activin receptor complex. Mol Cell Biol 1996; 16: 1066-1073.
25. TEN DIJKE P, MIYAZONO K, HELDIN C-H. Signalling via hetero-oligomeric complexes of type I and type II serine/ theorine kinase receptors. Curr Opin Cell Biol 1996; 8: 139-145.
26. MATHEWS LS. Activin reseptors and cellular signalling by the receptor serine kinase family. Endocr Rev 1994; 15: 310-325.
27. ROSENZWEIG BL, INAMURA T, OKADOME T, COX GN, YAMASHITA H, TEN DIJKE P, HELDIN CH, MIYAZONO K. Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci USA 1995; 92: 7632-7636.
28. MACIAS-SILVA M, ABDOLLAH S, HOODLESS PA, PIRONE R, ATTISANO L, WRANA JL. MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signalling. Cell 1996; 87: 1215-1224.
29. KRETZSCHMAR M, LIU F, HATA A, DOODY J, MASSAGUÉ J. The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes Dev 1997; 8: 984-995.
30. DERYNCK R, ZHANG Y. Intracellular signalling the Mad way to do it. Curr Biol 1996; 6: 1226-1229.
31. DE WINTER JP, TEN DIJKE P, DE VRIES CJM, VAN ACTERBERG TAE, DE WAELE P, HUYLEBROECK D, VERSCHUEREN K, VAN DEN EIJNDEN-VAN RAAIJ AJM. Follistatins neutralize activin bioactivity by inhibition of activin binding to its type II receptors. Mol Cell Endocrinol 1996; 116: 105-114.
32. TUURI T, ERÄMAA M, HILDÉN K, RITVOS O. The tissue distribution of activin beta A-and beta B-subunit and follistatin messenger ribonucleic acids suggest multiple sites of action for the activin-follistatin system during human development. J Clin Endocrinol Metab 1994; 78: 1521-1524.
33. MATZUK MM. Functional analysis of mammalian members of the transforming growth factor-β superfamily. Trends Endocrinol Metab 1995; 6: 120-127.
34. YAMASHITA H, TEN DIJKE P, HUYLEBROECK D, SAMPATH TK, ANDRIES M, SMITH JS, HELDIN C-H, MIYAZONO K. Osteogenic protein-1 binds to activin type II receptors and induces activin-like effects. J Cell Biol 1995, 130: 217-226.
35. SCHREWE H, GENDRON-MAGUIRE M, HARBISON M L, GRIDLEY T. Mice homozygous for a null mutation of activin βB are viable and fertile. Mech Dev 1994; 47: 43-51.
36. VASSALLI A, MATZUK MM, GARDNER HAR, LEE KF, JAENISCH R. Activin/inhibin βB subunit gene disruption leads to defects in eyelid development and female reproduction. Genes Dev 1994; 8: 414-427.
37. KAWABATA M, CHYTIL A, MOSES HL. Cloning a novel type IIserine/threonine kinase receptor through growth factor-beta receptor. J Biol Chem 1995; 270: 5625-5630.
38. NOHNO T, ISHIKAWA T, SAITO T, HOSOKAWA K, NOJI S, WOLSING DH, ROSENBAUM JS. Identification of a human type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptors. J Biol Chem 1995; 270: 22,522-22,526.
39. DUDLEY AT, LYONS KM, ROBERTSON EJ. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev 1995; 9: 2795-2807.
40. LUO G, HOFMANN C, BRONCKERS ALJJ, SOHOCKI M, BRADLEY A, KARSENTY G. BMP-7 is an inducer of nephoregenesis, and is also required for eye development and skeletal patterning. Genes Dev 1995; 9: 2808-2820.
41. WINNIER G, BLESSING M, LABOSKY PA, HOGAN BLM. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev 1995; 9: 2105-2116.
42. ZHANG M, BRADLEY A. Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 1996; 122: 2977-2986.
43. NAKASHIMA M, NAGASAWA H, YAMADA Y, REDDI HA. Regulatory role of transforming growth factor-β, bone morphogenetic protein-2 and protein-4 on gene expression of extracellular matrix proteins and differentiation of dental pulp cells. Dev Biol 1994; 162: 18-28.
44. HELDER MN. The bone morphogenetic proteins 3 and 7 (BMP-3 and BMP-7) in developing bones and teeth. Thesis. Amsterdam: Free University Press, 1994.
45. ZHAO G-Q, LABOSKY PA, LIAW L, HOGAN BLM. The gene encoding bone morphogenetic protein 8B is required for the initiation and maintenance of spermatogenesis in the mouse. Genes Dev 1996; 10: 1657-1669.
46. MISHINA Y, SUSUKI A, UENO N, BEHRINGER RR. Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes Dev 1995; 9: 3027-3037.
47. MATHEWS LS, VALE WW. Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell 1991; 65: 973-982.
48. YAMASHITA H, TEN DIJKE P, FRANZÉN P, MIYAZONO K, HELDIN C-H. Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-β. J Biol Chem 1994; 269: 20,172-20,178.
49. NISHITOH H, ICHIJO H, KIMURA M, MATSUMOTO T, MAKISHIMA F, YAMAGUCHI A, YAMASHITA H, ENOMOTO S, MIYAZONO K. Identification of type I and type II serine/ threonone kinase receptors for growth/differentiation factor-5. J Biol Chem 1996; 271: 21,345-21,352.
50. ATTISANO L, WRANA JL, CHEIFETZ S, MASSAGUÉ J. Novel activin receptors: distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors. Cell 1992; 68: 97-108.
51. LIN HY, WANG X-F, NG-EATON E, WEINBERG RA, LODISH HF. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 1992: 68: 775-785.
52. DI CLEMENTE N, WILSON C, FAURE E, BOUSSIN L, CARMILLO P, TIZARD R, PICARD JY, VIGIER B, Josso N, CATE R. Cloning, expression and alternative splicing of the receptor for anti-Mullerian hormone. Mol Endocrinol 1994; 8: 1006-1020.
53. TSUCHIDA K, MATHEWS LS, VALE WW. Cloning and characterization of a transmembrane serine kinase that acts as an activin type I receptor. Proc Natl Acad Sci USA 1993; 90: 11,242-11,246.
54. ATTISANO L, CARCAMO J, VENTURA F, WEIS FMB, MASSAGUÉ J, WRANA JL. Identification of human activin and TGF-β type I receptors that form heterometric kinase complexes with type II receptors. Cell 1993; 75: 671-680.
55. TEN DIJKE P, ICHIJO H, FRANZÉN P, SCHULZ P, SARAS J, TOYOSHIMA H, HELDIN C-H, MIYAZONO K. Activin receptor-like kinases: a novel subclass of cell surface receptors with predicted serine/threonine kinase activity. Oncogene 1993; 8: 2879-2887.
56. TEN DIJKE P, YAMASHITA H, ICHIJO H, FRANZEN P, LAIHO M, MIYAZONO K, HELDIN C-H. Characterization of type I receptors for transforming growth factor-β and activin. Science 1994; 264: 101-104.
57. FRANZÉN P, TEN DIJKE P, ICHIJO H, YAMASHITA H, SCHULTZ P, HELDIN C-H, MIYAZONO K. Cloning of a TGF-β type I receptor that forms a heteromeric complex with the TGF-β type II. Cell 1993; 75: 681-692.
58. TEN DIJKE P, YAMASHITA H, SAMPATH TK, REDDI AH, ESTEVEZ M, RIDDLE DL, ICHIJO H, HELDIN C-H, MIYAZONO K. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J Biol Chem 1994; 269: 16985-16988.
59. KOENIG BB, COOK JS, WOLSING DH, TING J, THIESMAN JP, CORREA PE, OLSON CA, PECQUET AL, VENTURA F, GRANT RA, CHEN G-X, WRANA JL, MASSAGUÉ J, ROSENBAUM JS. Characterization and cloning of a receptor for BMP-2 and BMP4 from NIH 3T3 cells. Mol Cell Biol 1994; 14: 5961-5974.
60. RYDÉN M, IMAMURA T, JORNVALL H, BELLUARDO N, NEVEU I, TRUPP M, OKADOME T, TEN DIJKE P, IBANEZ CF. A novel type I receptor serine/threonine kinase predominantly expressed in the adult central nervous system. J Biol Chem 1996; 271: 30603-30609.
61. OH SP, LI E. The signaling pathway mediated by the type IIB activin receptor controls axial patterning and lateral asymmetry in the mouse. Genes Dev 1997; 11: 1812-1826.